| pubmed-article:9873718 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9873718 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:9873718 | lifeskim:mentions | umls-concept:C0178576 | lld:lifeskim |
| pubmed-article:9873718 | lifeskim:mentions | umls-concept:C0242808 | lld:lifeskim |
| pubmed-article:9873718 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:9873718 | lifeskim:mentions | umls-concept:C2003852 | lld:lifeskim |
| pubmed-article:9873718 | lifeskim:mentions | umls-concept:C0917721 | lld:lifeskim |
| pubmed-article:9873718 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:9873718 | pubmed:dateCreated | 1999-1-26 | lld:pubmed |
| pubmed-article:9873718 | pubmed:abstractText | Interfacial peptides of HIV-1 protease were crosslinked with varying length alkyl-chains containing either a single cis or trans double bond, or a triple bond to remove degrees of freedom within the tethers. The synthesis of these compounds and their effects on the activity of HIV-1 protease are described. | lld:pubmed |
| pubmed-article:9873718 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873718 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9873718 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873718 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9873718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873718 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9873718 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9873718 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:9873718 | pubmed:author | pubmed-author:ChmielewskiJJ | lld:pubmed |
| pubmed-article:9873718 | pubmed:author | pubmed-author:UlysseL GLG | lld:pubmed |
| pubmed-article:9873718 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9873718 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:9873718 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:9873718 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9873718 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9873718 | pubmed:pagination | 3281-6 | lld:pubmed |
| pubmed-article:9873718 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9873718 | pubmed:meshHeading | pubmed-meshheading:9873718-... | lld:pubmed |
| pubmed-article:9873718 | pubmed:meshHeading | pubmed-meshheading:9873718-... | lld:pubmed |
| pubmed-article:9873718 | pubmed:meshHeading | pubmed-meshheading:9873718-... | lld:pubmed |
| pubmed-article:9873718 | pubmed:meshHeading | pubmed-meshheading:9873718-... | lld:pubmed |
| pubmed-article:9873718 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9873718 | pubmed:articleTitle | Restricting the flexibility of crosslinked, interfacial peptide inhibitors of HIV-1 protease. | lld:pubmed |
| pubmed-article:9873718 | pubmed:affiliation | Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA. | lld:pubmed |
| pubmed-article:9873718 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9873718 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9873718 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9873718 | lld:pubmed |
